Mpox (monkeypox)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 368.17 billion USD, with a 24h change of +1.22%. Among 5 constituents, 4 are up (80.00%) and 1 are down (20.00%). The top gainer is GeoVax Labs, Inc. New (GOVX), with a 24h increase of +3.05%.Leaders powered a modest sector advance with constructive breadth. Near term, focus on liquid bellwethers and tight risk controls; medium term, pace allocations with earnings cadence and the interest-rate path.